Delivery Order SPE2DB25D3005-SPE2DB25FQELY
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,174.55 contract is for the delivery of 500 units of 8 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,425,639 units of Ondansetron ODT 8 mg tablets, a medication commonly used to treat nausea and vomiting. The delivery order is valued at $1,085.14 and has a firm fixed price. The contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This delivery order is likely part of a larger...
This is a $7,576.73 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,828,438 units of the generic drug Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,991.66, is for the delivery of 4,566,405,648 units of Ondansetron HCl 4 mg Tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4,565,069,737 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $14,358.35 and a period of performance through July 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a delivery order placed by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,571,391 tablets of 4 mg Ondansetron Hydrochloride, a medication used to treat nausea and vomiting. The delivery order has a ceiling value of $1,464.35 and a completion date of December 2, 2024. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,563,866,919 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $5,111.82 and a period of performance through March 6, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,873,868 tablets of the medication Ondansetron HCL 4 mg, a common anti-nausea drug. The contract has a firm fixed price of $10,545.89 and a completion date of April 11, 2025. This contract is not set-aside and was awarded on April 10, 2025. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,296,427 units of Ondansetron ODT 4 MG tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $15,175.16 and a performance period ending on July 31, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 8 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,108.67 and a completion date of December 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...